Riskpilot← Back to searchSign inGet full accessHakimi Medical AB
ABActiveOrg 5592144876Karl Bondes Väg 15General medical practice activities · NACE 8621Est. 20191 employees
Revenue 2025
SEK 401K
+2% vs 2024
EBITDA margin
80.8%
+15% vs 2024
Equity ratio
70.9%
Financial strength
Net profit 2025
SEK 256K
+14% vs 2024
| Revenue | SEK 401K | +2% |
| EBITDA | SEK 324K | +15% |
| Net profit | SEK 256K | +14% |
| Total assets | SEK 442K | +9% |
| Equity | SEK 313K | +13% |
| Employees | 1 | — |
Legal name
Hakimi Medical AB
Org number
5592144876
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 augusti 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Konsultverksamhet där bolaget hyr ut personal till hälso- och sjukvården samt bedriver rådgivning, undervisning och utveckling inom medicin, friskvård, hälsa samt därmed förenlig verksamhet. Bolaget investerar även i värdepapper, fastigheter och fastighetsförvaltning och därmed förenlig verksamhet.
Address
Karl Bondes Väg 15
Email
robinhakimi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 183 | 262 | 244 | 395 | 401 |
| Staff expenses | — | −22 | — | −52 | −17 |
| EBITDA | 108 | 193 | 158 | 283 | 324 |
| Depreciation & amort. | −0 | — | −0 | — | — |
| EBIT | 108 | 193 | 158 | 283 | 324 |
| Net financials | — | −0 | −2 | −0 | 0 |
| Profit before tax | 108 | 193 | 156 | 282 | 324 |
| Tax | −22 | −40 | −32 | −58 | −68 |
| Net profit | 86 | 153 | 124 | 224 | 256 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 226 | 314 | 283 | 403 | 442 |
| Equity | 136 | 204 | 178 | 277 | 313 |
| Long-term debt | 0 | — | 0 | — | — |
| Short-term debt | 90 | 110 | 105 | 126 | 129 |
| Total debt | 90 | 110 | 105 | 126 | 129 |
EBITDA margin
80.8%
This company
15.8%
Market median
+411% vs market
20212025
Equity ratio
70.9%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
81.8%
This company
18.4%
Market median
+345% vs market
20212025
Net profit margin
63.9%
This company
8.1%
Market median
+689% vs market
20212025
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2020 | |
| Chairman | 2022 | |
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hakimi Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Petersdotter Natt och Dag | Board of Directors | 0 companies |
| Elin Neda Hakimi | Board of Directors | 0 companies |
| Robin Nima Natt och Dag Hakimi | Chairman | 0 companies |
| Elin Neda Hakimi | Board of Directors | 0 companies |
| Anna Petersdotter Natt och Dag | Board of Directors | 0 companies |